Applyo Jena devel­ops and dis­trib­utes lyophilized (freeze-dried) reagents for diag­nos­tics and life sci­ence research.

The Jena-based MedTech start-up PERCEPTEC is devel­op­ing a soft­­ware-based test pro­ce­dure that, in com­bi­na­tion with vision­ary 3D dis­play tech­nol­ogy, enables a vir­tual eye test to

DeepEn is a spin-off from Leib­niz Insti­tute for Pho­tonic Tech­nolo­gies (IPHT) in Jena and devel­ops hair-thin microen­do­scopes that deliver fast, high-res­o­lu­­tion images from inside sensitive

BION­CaRT GmbH emerged from Bio­Planta GmbH, which has been devel­op­ing and man­u­fac­tur­ing cell ther­apy prod­ucts from mes­enchy­mal stro­mal cells for clin­i­cal appli­ca­tion in humans and

Dig­ity GmbH is a com­pany in the field of exoskele­ton tech­nol­ogy. Founded in 2023 as a spin-off of the Uni­ver­sity Med­ical Cen­ter Göt­tin­gen, Dig­ity develops

Altavo GmbH is a Life Sci­ences com­pany that devel­ops pros­thet­ics based on non-inva­­sive radar sen­sor tech­nol­ogy and arti­fi­cial intel­li­gence to improve the reha­bil­i­ta­tion of voiceless

Flu­IDect devel­ops fully auto­mated biosen­sors and label-free pho­tonic read­out tech­nol­ogy for the online mon­i­tor­ing of liq­uid prod­ucts and process media for seam­less qual­ity con­trol of

INTERCUS offers the com­plete range of implants and instru­ments for frac­ture treat­ment as well as for the sur­gi­cal treat­ment of mus­cu­loskele­tal dis­or­ders. in addi­tion to

The Born Group is spe­cial­ized in the sales of phar­ma­ceu­ti­cal prod­ucts via its oper­a­tive sub­sidiary Glen­wood GmbH.

Per­son­al­ized dig­i­tal ther­a­pies for men­tal health and men­tal per­for­mance. In this fast-grow­ing mar­ket for neu­rother­a­pies, the com­pany offers non-inva­­sive options for men­tal health, pain management

Dy­nam­ic42 de­vel­ops, of­fers and cus­tomizes novel 3D mi­cro­phys­i­o­log­i­cal in vit­ro test sys­tems recre­at­ing hu­man or­gan key func­tions. Our hu­man in vit­ro model sys­tems en­able a

The inno­v­a­tive 3D screen print­ing tech­nol­ogy from Laxxon Med­ical Corp. opens up new, pre­vi­ously unknown pos­si­bil­i­ties for opti­mized and inno­v­a­tive drug deliv­ery sys­tems (DDS) for

TrophoSYS GmbH devel­ops processes and inno­v­a­tive devices in the field of biotech­nol­ogy that enable sex-spe­­cific germ cell seg­re­ga­tion and live/dead cell sep­a­ra­tion in live­stock breeding.

devie med­ical GmbH is involved in the devel­op­ment, man­u­fac­ture and sale of a drug-releas­ing heart valve.

Germs are invis­i­ble… but why dis­in­fec­tion? Hey­fair’s pro­pri­etary dye sys­tems briefly color treated sur­faces dur­ing dis­in­fec­tion and thus imme­di­ately show whether dis­in­fec­tion is effec­tive and

Smart­Dye­Liv­ery devel­ops patented processes to deliver ther­a­peu­tics to the tar­get tis­sue in a highly spe­cific and effec­tive man­ner. Com­pared to con­ven­tional meth­ods, the active ingredients